Clinical Report: Study Investigates DR in Native Americans
Overview
A systematic review and meta-analysis has revealed that the prevalence of diabetic retinopathy (DR) among American Indians/Alaska Natives (AI/AN) is comparable to that of non-AI/AN populations, with any DR present in 21% of AI/AN patients. The study highlights the need for improved screening and treatment access in underserved populations.
Background
Diabetic retinopathy is a significant complication of diabetes that can lead to vision loss. Indigenous Americans experience higher rates of diabetes, yet the prevalence of DR in this population has been under-researched. Understanding the prevalence and complications of DR in AI/AN communities is crucial for addressing health disparities and improving patient outcomes.
Data Highlights
| Population | Any DR | PDR | DME | VTDR |
|---|---|---|---|---|
| AI/AN | 21% | 3% | 3% | 3% |
| Non-AI/AN | 20% | 2% | 3% | 5% |
Key Findings
- 21% of AI/AN patients with diabetes have any DR, similar to 20% in non-AI/AN patients.
- PDR is observed in 3% of AI/AN patients compared to 2% in non-AI/AN patients.
- 3% of both groups have diabetic macular edema (DME).
- Vision-threatening DR (VTDR) is reported in 3% of AI/AN patients and 5% of non-AI/AN patients.
- Longer diabetes duration correlates with higher DR prevalence in non-AI/AN patients.
- HbA1c levels of at least 8% are associated with increased DME prevalence.
Clinical Implications
Healthcare providers should prioritize screening for diabetic retinopathy in AI/AN populations, utilizing teleophthalmology and AI-based diagnostics to enhance access. Understanding the similarities in DR prevalence between AI/AN and non-AI/AN patients can inform targeted interventions and resource allocation.
Conclusion
Summarize key strategies for addressing disparities as highlighted in the source.
References
- CDC, ScienceDirect, 2025 -- The Prevalence of Diabetic Retinopathy in American Indians or Alaska Natives and Non-Indigenous Americans: A Systematic Review and Meta-Analysis
- DCCT/EDIC, PMC, 2015 -- Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC
- Clinical Rheumatology — Prevalence and Patterns of Rheumatic Diseases Among Indigenous Groups in Latin America
- npj Digital Medicine — Comparing content within a culturally-adapted digital treatment for Hispanic patients with alcohol use disorder
- Clinical Rheumatology — Racial and Ethnic Variations in Disease Burden Among Individuals with Rheumatoid Arthritis
- the asco post — Screening Was Key to the Early Detection of My Prostate Cancer
- The Prevalence of Diabetic Retinopathy in American Indians or Alaska Natives and Non-Indigenous Americans: A Systematic Review and Meta-Analysis - ScienceDirect
- Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC - PMC
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
